Evidence map›Paper›PMID 38304638›Full record

ArticleCureus2024

Coagulation Status Using Clot Wave Analysis in Patients With Prolonged Immobilization.

Salfarina Iberahim, Rosmaniza Muhamat Yusoff, Noor Haslina Mohd Noor, Rosline Hassan, Noor Nabila Ramli, Rosnah Bahar, Zefarina Zulkafli, Wan Suriana Wan Ab Rahman, Azly Sumanty Ab Ghani

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Salfarina IberahimHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Rosmaniza Muhamat YusoffHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Noor Haslina Mohd NoorHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Rosline HassanHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Noor Nabila RamliHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Rosnah BaharHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Zefarina ZulkafliHematology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Wan Suriana Wan Ab RahmanBasic and Medical Sciences Unit, School of Dental Sciences, Universiti Sains Malaysia, Kota Bharu, MYS.
Azly Sumanty Ab GhaniPathology, Hospital Sultanah Nur Zahirah, Kuala Terengganu, MYS.
Hospital Universiti Sains Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Prolonged immobilization is widely recognized as a risk factor for thromboembolism. In this prospective study, we investigated the changes in clot waveform analysis (CWA) parameters in prolonged immobilized patients following lower limb trauma. CWA is an advanced method for assessing global coagulation that involves continuously monitoring changes in light transmittance, absorbance, or light scattering during routine clotting tests. Additionally, we also aim to determine the CWA parameters between day one and after day three of immobilization. Methods A total of 30 patients with prolonged immobilization were enrolled in this study. The plasma of these patients was collected on the first day of their admission and subsequently obtained again after day three of immobilization. Prothrombin time (PT)-based CWA and activated partial thromboplastin time (aPTT)-based CWA were performed using the ACL TOP 300 CTS (Werfen: Bedford, USA) coagulation analyzer, which utilizes the optical method for clot detection. Plasma samples for 20 normal controls were recruited from a healthy blood donor. The CWA parameters generated during clot formation were analyzed. For the comparison of CWA parameters between patients with prolonged immobilization and healthy controls, the Mann-Whitney test was used. A paired t-test was used for the comparison of clot wave parameters between day one and after day three of immobilization. This study was approved by the Universiti Sains Malaysia Research Ethics Committee. Result The mean values of PT and aPTT in healthy controls were 11.66 seconds and 33.98 seconds, respectively. There was no statistically significant difference between the patients and the healthy controls in the median values of aPTT (P=0.935). However, patients with prolonged immobilization exhibited significantly higher median PT CWA parameter values than controls (P=0.007). These parameters included the delta change (P<0.001), peak time velocity (P=0.008), and height velocity (P<0.001). On the other hand, the delta change (P<0.001) and height velocity (P<0.001) of the aPTT CWA parameters were significantly higher in patients with prolonged immobilization than in controls. In patients with prolonged immobilization, there was no significant difference in PT CWA parameters between day one and after day three of immobilization, while for aPTT CWA, all parameters were higher on day three, except for the endpoint time. Conclusion Patients with prolonged immobilization exhibit increased PT and aPTT CWA parameters compared to normal controls. CWA parameters could aid in identifying patients at risk of developing thrombosis through changes in the clot waveform. However, further study is needed to fully utilize additional information from routine coagulation testing.

Indexed as

activated partial thromboplastin time (aptt)apttcwaprolonged immobilizationprothrombin time (pt)pt

Identifiers

PMID38304638
PMCPMC10830393
OpenAlexW4390486383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.